{"assetProfile": {"address1": "177 East Colorado Boulevard", "address2": "Suite 700", "city": "Pasadena", "state": "CA", "zip": "91105", "country": "United States", "phone": "626 304 3400", "fax": "626 304 3401", "website": "https://arrowheadpharma.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's product pipeline includes Plozasiran, which has completed Phase 3 clinical trial to treat hypertriglyceridemia, dyslipidemia, and familial chylomicronemia syndrome; Olpasiran that is in Phase 3 clinical trial to reduce the production of apolipoprotein A; and Fazirsiran that is in Phase 3 clinical trial for the treatment of liver disease associated with alpha-1 antitrypsin deficiency. It also develops Zodasiran that is in Phase 2b clinical trial for the treatment of dyslipidemia and hypertriglyceridemia; GSK-4532990 to treat metabolic-dysfunction associated steatohepatitis (MASH); and Daplusiran/Tomligisiran which is in Phase 2 clinical trial for the treatment of Chronic Hepatitis B. In addition, the company is developing ARO-PNPLA3, which is in Phase 1 clinical trial to treat patients with MASH; ARO-INHBE to reduce the hepatic expression of the INHBE gene and its secreted gene product; ARO-RAGE to treat inflammatory lung disease; ARO-MUC5AC to treat muco-obstructive pulmonary diseases; and ARO-MMP7 for the treatment of idiopathic pulmonary fibrosis that is in Phase 1/2a clinical trials. Further, it develops ARO-DUX4 for the treatment of facioscapulohumeral muscular dystrophy; ARO-DM1 to treat patient with Type 1 Myotonic Dystrophy; ARO-C3 to treat complement-mediated renal disease; ARO-CFB for the treatment of complement-mediated kidney disease that is in Phase 1/2a clinical trial; and ARO-ATXN2 for the treatment of Spinocerebellar Ataxia Type 2 that is in Phase 1 clinical trial. Arrowhead Pharmaceuticals, Inc. has collaboration and license Agreements with Glaxosmithkline Intellectual Property (No. 3) Limited; Horizon Therapeutics Ireland DAC; Takeda Pharmaceutical Company Limited; and with Amgen Inc. The company was founded in 2003 and is headquartered in Pasadena, California.", "fullTimeEmployees": 609, "companyOfficers": [{"maxAge": 1, "name": "Dr. Christopher R. Anzalone Ph.D.", "age": 55, "title": "Chairman, CEO & President", "yearBorn": 1969, "fiscalYear": 2024, "totalPay": {"raw": 2104473, "fmt": "2.1M", "longFmt": "2,104,473"}, "exercisedValue": {"raw": 1024000, "fmt": "1.02M", "longFmt": "1,024,000"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Patrick  O'Brien J.D., PharmD", "age": 60, "title": "COO, General Counsel & Secretary", "yearBorn": 1964, "fiscalYear": 2024, "totalPay": {"raw": 998520, "fmt": "998.52k", "longFmt": "998,520"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. James C. Hamilton M.D., MBA", "age": 46, "title": "Chief Medical Officer and Head of R&D", "yearBorn": 1978, "fiscalYear": 2024, "totalPay": {"raw": 897694, "fmt": "897.69k", "longFmt": "897,694"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Mark M. Davis Ph.D.", "title": "Founder and Founder & Director of Insert Therapeutics Inc & Calando", "fiscalYear": 2024, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Daniel J. Apel", "title": "Chief Financial Officer", "fiscalYear": 2024, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Vincent  Anzalone CFA", "title": "Head of Investor Relations & VP", "fiscalYear": 2024, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Howard  Lovy", "title": "Director of Communications", "fiscalYear": 2024, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Bruce D. Given M.D.", "age": 70, "title": "Chief Medical Scientist", "yearBorn": 1954, "fiscalYear": 2024, "totalPay": {"raw": 486308, "fmt": "486.31k", "longFmt": "486,308"}, "exercisedValue": {"raw": 5934362, "fmt": "5.93M", "longFmt": "5,934,362"}, "unexercisedValue": {"raw": 6159876, "fmt": "6.16M", "longFmt": "6,159,876"}}, {"maxAge": 1, "name": "Dr. Mark  Seefeld", "age": 70, "title": "Head of Toxicology & VP", "yearBorn": 1954, "fiscalYear": 2024, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Aaron  Tan", "title": "Head of Tax", "fiscalYear": 2024, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "auditRisk": 8, "boardRisk": 7, "compensationRisk": 2, "shareHolderRightsRisk": 1, "overallRisk": 2, "governanceEpochDate": 1761955200, "compensationAsOfEpochDate": 1735603200, "irWebsite": "http://www.arrowheadresearch.com/invest.html", "executiveTeam": [], "maxAge": 86400}, "calendarEvents": {"maxAge": 1, "earnings": {"earningsDate": [{"raw": 1764190800, "fmt": "2025-11-26"}], "earningsCallDate": [{"raw": 1754598600, "fmt": "2025-08-07"}], "isEarningsDateEstimate": true, "earningsAverage": {"raw": -0.37636, "fmt": "-0.38"}, "earningsLow": {"raw": -1.18, "fmt": "-1.18"}, "earningsHigh": {"raw": 0.69, "fmt": "0.69"}, "revenueAverage": {"raw": 147530000, "fmt": "147.53M", "longFmt": "147,530,000"}, "revenueLow": {"raw": 0, "fmt": null, "longFmt": "0"}, "revenueHigh": {"raw": 255000000, "fmt": "255M", "longFmt": "255,000,000"}}, "exDividendDate": {}, "dividendDate": {}}, "earningsTrend": {"trend": [{"maxAge": 1, "period": "0q", "endDate": "2025-09-30", "growth": {"raw": 0.7253, "fmt": "72.53%"}, "earningsEstimate": {"avg": {"raw": -0.37636, "fmt": "-0.38"}, "low": {"raw": -1.18, "fmt": "-1.18"}, "high": {"raw": 0.69, "fmt": "0.69"}, "yearAgoEps": {"raw": -1.37, "fmt": "-1.37"}, "numberOfAnalysts": {"raw": 11, "fmt": "11", "longFmt": "11"}, "growth": {"raw": 0.7253, "fmt": "72.53%"}, "earningsCurrency": "USD"}, "revenueEstimate": {"avg": {"raw": 147530000, "fmt": "147.53M", "longFmt": "147,530,000"}, "low": {"raw": 0, "fmt": null, "longFmt": "0"}, "high": {"raw": 255000000, "fmt": "255M", "longFmt": "255,000,000"}, "numberOfAnalysts": {"raw": 12, "fmt": "12", "longFmt": "12"}, "yearAgoRevenue": {"raw": 0, "fmt": null, "longFmt": "0"}, "growth": {"raw": 0.0, "fmt": "0.00%"}, "revenueCurrency": "USD"}, "epsTrend": {"current": {"raw": -0.37636, "fmt": "-0.38"}, "7daysAgo": {"raw": -0.32415, "fmt": "-0.32"}, "30daysAgo": {"raw": -0.27831, "fmt": "-0.28"}, "60daysAgo": {"raw": -0.18187, "fmt": "-0.18"}, "90daysAgo": {"raw": -0.41943, "fmt": "-0.42"}, "epsTrendCurrency": "USD"}, "epsRevisions": {"upLast7days": {"raw": 0, "fmt": null, "longFmt": "0"}, "upLast30days": {"raw": 0, "fmt": null, "longFmt": "0"}, "downLast30days": {"raw": 3, "fmt": "3", "longFmt": "3"}, "downLast7Days": {"raw": 1, "fmt": "1", "longFmt": "1"}, "downLast90days": {}, "epsRevisionsCurrency": "USD"}}, {"maxAge": 1, "period": "+1q", "endDate": "2025-12-31", "growth": {"raw": 1.2386, "fmt": "123.86%"}, "earningsEstimate": {"avg": {"raw": 0.33167, "fmt": "0.33"}, "low": {"raw": -1.14, "fmt": "-1.14"}, "high": {"raw": 2.0, "fmt": "2"}, "yearAgoEps": {"raw": -1.39, "fmt": "-1.39"}, "numberOfAnalysts": {"raw": 6, "fmt": "6", "longFmt": "6"}, "growth": {"raw": 1.2386, "fmt": "123.86%"}, "earningsCurrency": "USD"}, "revenueEstimate": {"avg": {"raw": 244292000, "fmt": "244.29M", "longFmt": "244,292,000"}, "low": {"raw": 23000000, "fmt": "23M", "longFmt": "23,000,000"}, "high": {"raw": 468842000, "fmt": "468.84M", "longFmt": "468,842,000"}, "numberOfAnalysts": {"raw": 6, "fmt": "6", "longFmt": "6"}, "yearAgoRevenue": {"raw": 2500000, "fmt": "2.5M", "longFmt": "2,500,000"}, "growth": {"raw": 96.7168, "fmt": "9,671.68%"}, "revenueCurrency": "USD"}, "epsTrend": {"current": {"raw": 0.33167, "fmt": "0.33"}, "7daysAgo": {"raw": 0.34167, "fmt": "0.34"}, "30daysAgo": {"raw": 0.095, "fmt": "0.09"}, "60daysAgo": {"raw": -0.645, "fmt": "-0.64"}, "90daysAgo": {"raw": -0.51333, "fmt": "-0.51"}, "epsTrendCurrency": "USD"}, "epsRevisions": {"upLast7days": {"raw": 0, "fmt": null, "longFmt": "0"}, "upLast30days": {"raw": 2, "fmt": "2", "longFmt": "2"}, "downLast30days": {"raw": 1, "fmt": "1", "longFmt": "1"}, "downLast7Days": {"raw": 1, "fmt": "1", "longFmt": "1"}, "downLast90days": {}, "epsRevisionsCurrency": "USD"}}, {"maxAge": 1, "period": "0y", "endDate": "2025-09-30", "growth": {"raw": 0.9442, "fmt": "94.42%"}, "earningsEstimate": {"avg": {"raw": -0.27909, "fmt": "-0.28"}, "low": {"raw": -1.06, "fmt": "-1.06"}, "high": {"raw": 0.82, "fmt": "0.82"}, "yearAgoEps": {"raw": -5.0, "fmt": "-5"}, "numberOfAnalysts": {"raw": 11, "fmt": "11", "longFmt": "11"}, "growth": {"raw": 0.9442, "fmt": "94.42%"}, "earningsCurrency": "USD"}, "revenueEstimate": {"avg": {"raw": 730730840, "fmt": "730.73M", "longFmt": "730,730,840"}, "low": {"raw": 573000000, "fmt": "573M", "longFmt": "573,000,000"}, "high": {"raw": 923000000, "fmt": "923M", "longFmt": "923,000,000"}, "numberOfAnalysts": {"raw": 14, "fmt": "14", "longFmt": "14"}, "yearAgoRevenue": {"raw": 3551000, "fmt": "3.55M", "longFmt": "3,551,000"}, "growth": {"raw": 204.7817, "fmt": "20,478.17%"}, "revenueCurrency": "USD"}, "epsTrend": {"current": {"raw": -0.27909, "fmt": "-0.28"}, "7daysAgo": {"raw": -0.27909, "fmt": "-0.28"}, "30daysAgo": {"raw": -0.2183, "fmt": "-0.22"}, "60daysAgo": {"raw": -0.13432, "fmt": "-0.13"}, "90daysAgo": {"raw": -0.17868, "fmt": "-0.18"}, "epsTrendCurrency": "USD"}, "epsRevisions": {"upLast7days": {"raw": 0, "fmt": null, "longFmt": "0"}, "upLast30days": {"raw": 0, "fmt": null, "longFmt": "0"}, "downLast30days": {"raw": 3, "fmt": "3", "longFmt": "3"}, "downLast7Days": {"raw": 1, "fmt": "1", "longFmt": "1"}, "downLast90days": {}, "epsRevisionsCurrency": "USD"}}, {"maxAge": 1, "period": "+1y", "endDate": "2026-09-30", "growth": {"raw": -9.3616, "fmt": "-936.16%"}, "earningsEstimate": {"avg": {"raw": -2.89182, "fmt": "-2.89"}, "low": {"raw": -5.01, "fmt": "-5.01"}, "high": {"raw": -0.85, "fmt": "-0.85"}, "yearAgoEps": {"raw": -0.27909, "fmt": "-0.28"}, "numberOfAnalysts": {"raw": 11, "fmt": "11", "longFmt": "11"}, "growth": {"raw": -9.3616, "fmt": "-936.16%"}, "earningsCurrency": "USD"}, "revenueEstimate": {"avg": {"raw": 390316890, "fmt": "390.32M", "longFmt": "390,316,890"}, "low": {"raw": 90000000, "fmt": "90M", "longFmt": "90,000,000"}, "high": {"raw": 646800000, "fmt": "646.8M", "longFmt": "646,800,000"}, "numberOfAnalysts": {"raw": 14, "fmt": "14", "longFmt": "14"}, "yearAgoRevenue": {"raw": 730730840, "fmt": "730.73M", "longFmt": "730,730,840"}, "growth": {"raw": -0.4659, "fmt": "-46.59%"}, "revenueCurrency": "USD"}, "epsTrend": {"current": {"raw": -2.89182, "fmt": "-2.89"}, "7daysAgo": {"raw": -3.08636, "fmt": "-3.09"}, "30daysAgo": {"raw": -2.87972, "fmt": "-2.88"}, "60daysAgo": {"raw": -3.38528, "fmt": "-3.39"}, "90daysAgo": {"raw": -3.45019, "fmt": "-3.45"}, "epsTrendCurrency": "USD"}, "epsRevisions": {"upLast7days": {"raw": 1, "fmt": "1", "longFmt": "1"}, "upLast30days": {"raw": 1, "fmt": "1", "longFmt": "1"}, "downLast30days": {"raw": 1, "fmt": "1", "longFmt": "1"}, "downLast7Days": {"raw": 0, "fmt": null, "longFmt": "0"}, "downLast90days": {}, "epsRevisionsCurrency": "USD"}}], "defaultMethodology": "nongaap", "maxAge": 1}, "earningsHistory": {"history": [{"maxAge": 1, "epsActual": {"raw": -1.37, "fmt": "-1.37"}, "epsEstimate": {"raw": -0.92196, "fmt": "-0.92"}, "epsDifference": {"raw": -0.45, "fmt": "-0.45"}, "surprisePercent": {"raw": -0.48599997, "fmt": "-48.60%"}, "quarter": {"raw": 1727654400, "fmt": "2024-09-30"}, "currency": "USD", "period": "-4q"}, {"maxAge": 1, "epsActual": {"raw": -1.39, "fmt": "-1.39"}, "epsEstimate": {"raw": -0.72337, "fmt": "-0.72"}, "epsDifference": {"raw": -0.67, "fmt": "-0.67"}, "surprisePercent": {"raw": -0.92160004, "fmt": "-92.16%"}, "quarter": {"raw": 1735603200, "fmt": "2024-12-31"}, "currency": "USD", "period": "-3q"}, {"maxAge": 1, "epsActual": {"raw": 2.75, "fmt": "2.75"}, "epsEstimate": {"raw": -0.46215, "fmt": "-0.46"}, "epsDifference": {"raw": 3.21, "fmt": "3.21"}, "surprisePercent": {"raw": 6.9504, "fmt": "695.04%"}, "quarter": {"raw": 1743379200, "fmt": "2025-03-31"}, "currency": "USD", "period": "-2q"}, {"maxAge": 1, "epsActual": {"raw": -1.26, "fmt": "-1.26"}, "epsEstimate": {"raw": -1.10134, "fmt": "-1.1"}, "epsDifference": {"raw": -0.16, "fmt": "-0.16"}, "surprisePercent": {"raw": -0.1441, "fmt": "-14.41%"}, "quarter": {"raw": 1751241600, "fmt": "2025-06-30"}, "currency": "USD", "period": "-1q"}], "defaultMethodology": "nongaap", "maxAge": 86400}, "financialData": {"maxAge": 86400, "currentPrice": {"raw": 39.61, "fmt": "39.61"}, "targetHighPrice": {"raw": 80.0, "fmt": "80.00"}, "targetLowPrice": {"raw": 17.0, "fmt": "17.00"}, "targetMeanPrice": {"raw": 47.5, "fmt": "47.50"}, "targetMedianPrice": {"raw": 45.0, "fmt": "45.00"}, "recommendationMean": {"raw": 1.84615, "fmt": "1.85"}, "recommendationKey": "buy", "numberOfAnalystOpinions": {"raw": 12, "fmt": "12", "longFmt": "12"}, "totalCash": {"raw": 898172032, "fmt": "898.17M", "longFmt": "898,172,032"}, "totalCashPerShare": {"raw": 6.496, "fmt": "6.5"}, "ebitda": {"raw": -85396000, "fmt": "-85.4M", "longFmt": "-85,396,000"}, "totalDebt": {"raw": 713286016, "fmt": "713.29M", "longFmt": "713,286,016"}, "quickRatio": {"raw": 4.667, "fmt": "4.67"}, "currentRatio": {"raw": 4.868, "fmt": "4.87"}, "totalRevenue": {"raw": 572976000, "fmt": "572.98M", "longFmt": "572,976,000"}, "debtToEquity": {"raw": 137.222, "fmt": "137.22%"}, "revenuePerShare": {"raw": 4.395, "fmt": "4.39"}, "returnOnAssets": {"raw": -0.0596, "fmt": "-5.96%"}, "returnOnEquity": {"raw": -0.37111, "fmt": "-37.11%"}, "grossProfits": {"raw": 572976000, "fmt": "572.98M", "longFmt": "572,976,000"}, "freeCashflow": {"raw": -48370124, "fmt": "-48.37M", "longFmt": "-48,370,124"}, "operatingCashflow": {"raw": 21845000, "fmt": "21.84M", "longFmt": "21,845,000"}, "earningsGrowth": {}, "revenueGrowth": {}, "grossMargins": {"raw": 1.0, "fmt": "100.00%"}, "ebitdaMargins": {"raw": -0.14904, "fmt": "-14.90%"}, "operatingMargins": {"raw": -5.96211, "fmt": "-596.21%"}, "profitMargins": {"raw": -0.25902998, "fmt": "-25.90%"}, "financialCurrency": "USD"}}